Citadel Advisors »

Tonix Pharmaceuticals Hldg shares owned by Citadel Advisors

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg (TNXP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Tonix Pharmaceuticals Hldg

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0M 512k 13.75
2025-12-31 $622k 40k 15.62
2025-06-30 $255k 7.1k 35.98

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Tonix Pharmaceuticals Hldg

BlackRock
Vanguard Group
Vanguard Capital Management
Citadel Advisors
Jones Hill Capital
Geode Capital Management
Balyasny Asset Management
UBS Group
Millennium Management
State Street Corporation
Northern Trust
AQR Capital Management
Point72 Asset Management
Jane Street
Nuveen

View all funds holding Tonix Pharmaceuticals Hldg